PK TDF in Thai HIV-infected Children

• Status: Completed
• Trial end date: 2012-05-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will assess the pharmacokinetics of TDF in Thai HIV-infected children

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The HIV Netherlands Australia Thailand Research Collaboration
• Collaborators: Chulalongkorn University; Khon Kaen University
• Treatments: Atazanavir Sulfate; Efavirenz; HIV Protease Inhibitors; Lopinavir; Protease Inhibitors; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir

Criteria

Inclusion Criteria:

• children between the ages of 8-18 years with documented HIV infection

• currently on TDF once daily regimen

• have signed the informed consent

Exclusion Criteria:

• the child or care taker refuse to participate in the study

• severity of adverse events is more than grade 3 thirty days before participating in the study